| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $71.3M | +45.3% |
| R&D Expense | $9.6M | -4.3% |
| SG&A Expense | $80.5M | +19.4% |
| Operating Income | -$34.5M | +16.6% |
| Interest Expense | $8.3M | -13.4% |
| Income Tax | $0 | — |
| Net Income | -$42.9M | +17.7% |
| EPS (Basic) | -$0.33 | +48.4% |
| EPS (Diluted) | -$0.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.2M | -0.1% |
| Accounts Receivable | $8.6M | +12.0% |
| Current Assets | $39.5M | -0.5% |
| Total Assets | $97.2M | -1.9% |
| Current Liabilities | $14.3M | -57.2% |
| Long-term Debt | $40.0M | -0.1% |
| Total Liabilities | $76.4M | -19.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.6M | -112.7% |
| Capital Expenditures | $3.2M | -85.9% |
| Investing Cash Flow | -$3.4M | +85.1% |
| Financing Cash Flow | $52.0M | +78.7% |
| Free Cash Flow | -$51.9M | -13.3% |
| +48.4% |
| Stockholders' Equity |
| $20.9M |
| +355.8% |